At his practice on-site at Lebanon Internal Medicine Associates, Dr. Fishman utilizes advanced technology now offering ...

This form of neuropathy carries a high risk of pain, trophic changes and autonomic dysfunction. There is currently no effective treatment for diabetic neuropathy, and good glycemic control is the ...

MIRA Pharmaceuticals (MIRA) announced that its novel oral ketamine analog, Ketamir-2, has shown greater pain relief compared to FDA-approved ...

Diabetic peripheral neuropathy, which affects about 30% of diabetics, can cause numbness, tingling, or burning in the feet.

Just over a year after its first phase 3 trial of its Engensis gene therapy for painful diabetic peripheral neuropathy (DPN ... At the moment treatment is limited to drugs like gabapentin and ...

Peripheral neuropathy, a condition affecting millions of people worldwide, can cause chronic pain, numbness, and weakness, ...

Having cold feet and no other symptoms may not be related to a condition but to an environmental factor. Find medical reasons ...

Under the licensing agreement, Alkem will carry out the clinical development of 'SON-080' in India with support from Sonnet ...

Alkem Laboratories partners with Sonnet BioTherapeutics to develop and commercialize SON-080, a potential treatment for ...

Sonnet BioTherapeutics Holdings ( (SONN) ) has issued an update. Sonnet BioTherapeutics Holdings, Inc. has partnered with ...

Sonnet BioTherapeutics Holdings, Inc. (SONN) announced Wednesday that it has entered into a licensing agreement with Alkem ...

India is grappling with a substantial burden of diabetes-related complications with diabetic peripheral neuropathy being a ...